Developed by Baya Lobo LLC, the tool utilizes one-compartment modeling to project how compounds like GHRH and GHRP secretagogues behave within the body. Beyond individual half-lives, the software simulates downstream cascades, such as the relationship between growth hormone release and subsequent IGF-1 response. Users can adjust variables including route of administration and clearance modifiers to refine these projections.
Founder Jim Hamilton noted that he developed the software after failing to find existing tools capable of handling complex peptide stacks. To maintain a focus on research utility, the app explicitly avoids AI-driven dosing suggestions or medical advice. The interface includes pre-configured templates for common stacks, inventory management, and PDF export functionality for clinical review.
Available immediately via web browser, the service operates on a subscription or lifetime license model, starting at $1.99 per month. An Android version is currently in final testing for the Google Play Store, with an iOS release planned to follow.
Comments (0)
No comments yet. Be the first!